PF-Atlas › Clinical Trials › NCT05932303

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

BMS-986278 · Phase 1

Registry ID
NCT05932303
Phase
Phase 1
Status
Completed
Drug / intervention
BMS-986278
Sponsor
Bristol-Myers Squibb
Start
2023-07-12
Enrollment
47
Locations
1

About this trial

This is a study in healthy participants designed to assess the effect of multiple doses of itraconazole, gemfibrozil, or carbamazepine on the drug levels of a single-dose of BMS-986278.

View NCT05932303 on ClinicalTrials.gov →

Explore related

Admilparant / BMS-986278 — Treatment profileAll BMS-986278 trialsAll IPF trials

Related trials

BMS-986278 — NCT06003426BMS-986278 — NCT05985590BMS-986278 — NCT06025578BMS-986278 — NCT03981094
Medical disclaimer. This page summarizes public trial data for NCT05932303 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.